Clinical Trial

Chemical vs Mechanical Pleural Adhesiolysis for Liberation of Captive Pleura in Stacked Effusion

Completed Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare the clinical and radiological efficacy of chemical pleural adhesiolysis (using either intrapleural 3% hydrogen peroxide or intrapleural corticosteroids) versus mechanical pleural adhesiolysis (via medical thoracoscopy) in patients with non-malignant, complicated parapneumonic pleural effusion (CPPE). Complicated pleural effusions often lead to the formation of fibrinous septa and adhesions, which impair drainage and prevent lung re-expansion. Standard interventions like tissue plasminogen activator (tPA) and DNase can be costly and limited in resource-constrained settings, while thoracoscopic mechanical pleurolysis requires specialized expertise and equipment. The investigators aim to evaluate whether chemical adhesiolysis using accessible, cost-effective agents (hydrogen peroxide or steroids) can offer a comparable and reliable alternative to thoracoscopic mechanical disruption of septa. Efficacy will be assessed using a novel composite clinical and radiological efficiency score evaluated seven days post-procedure.
Trial Details
NCT Number NCT07713329
Lead Sponsor Delta University for Science and Technology
Conditions Pleural Infection, Pleural Adhesions, Pleural Effusion, Pleural Empyema
Enrollment 36 participants
Start Date 2026-03-26
Primary Completion 2026-06-27 (estimated)
Study Completion 2026-06-27 (estimated)
Updated on ClinicalTrials.gov 2026-07-20